177 related articles for article (PubMed ID: 37816389)
21. Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population.
Aranda G; Halperin I; Gomez-Gil E; Hanzu FA; Seguí N; Guillamon A; Mora M
Front Endocrinol (Lausanne); 2021; 12():718200. PubMed ID: 34659112
[TBL] [Abstract][Full Text] [Related]
22. Continuing perioperative estrogen therapy does not increase venous thromboembolic events in transgender patients: a systematic review and meta-analysis.
Badreddine J; Lee MH; Mishra K; Pope R; Kim JY; Hong SH; Gupta S; Song JM; Shin JI; Ghayda RA
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2511-2517. PubMed ID: 35442466
[TBL] [Abstract][Full Text] [Related]
23. Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents.
Millington K; Lee JY; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM
Pediatrics; 2024 May; 153(5):. PubMed ID: 38567424
[TBL] [Abstract][Full Text] [Related]
24. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
Zaliznyak M; Jung EE; Bresee C; Garcia MM
J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
[TBL] [Abstract][Full Text] [Related]
25. Clinically Relevant Laboratory Monitoring of Gender-Affirming Hormone Therapy in Transgender People-Experiences from a Teaching Hospital in the Netherlands.
Pouw N; van der Linden J; Teuben S; Kos S
J Appl Lab Med; 2024 May; 9(3):440-455. PubMed ID: 38452266
[TBL] [Abstract][Full Text] [Related]
26. Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis.
Scarabin PY
Climacteric; 2018 Aug; 21(4):341-345. PubMed ID: 29570359
[TBL] [Abstract][Full Text] [Related]
27. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
Canonico M
Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
[TBL] [Abstract][Full Text] [Related]
28. Adherence to Gender Affirming Hormone Therapy in Transgender Adolescents and Adults: A Retrospective Cohort Study.
Gupta P; Patterson BC; Chu L; Gold S; Amos S; Yeung H; Goodman M; Tangpricha V
J Clin Endocrinol Metab; 2023 Oct; 108(11):e1236-e1244. PubMed ID: 37246711
[TBL] [Abstract][Full Text] [Related]
29. Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.
Santi D; Spaggiari G; Marinelli L; Cacciani M; Scipio S; Bichiri A; Profeta A; Granata ARM; Simoni M; Lanfranco F; Manieri C; Ghigo E; Motta G
J Endocrinol Invest; 2024 May; 47(5):1091-1100. PubMed ID: 37889433
[TBL] [Abstract][Full Text] [Related]
30. Transgender health and the impact of aging and menopause.
Cheung AS; Nolan BJ; Zwickl S
Climacteric; 2023 Jun; 26(3):256-262. PubMed ID: 37011669
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
[TBL] [Abstract][Full Text] [Related]
32. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
[TBL] [Abstract][Full Text] [Related]
33. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
[TBL] [Abstract][Full Text] [Related]
34. Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial.
Dijkman BAM; Helder D; Boogers LS; Gieles NC; van Heesewijk JO; Slaa ST; Liberton NPTJ; Wiepjes CM; de Blok CJM; den Heijer M; Dreijerink KMA
BMC Pharmacol Toxicol; 2023 Dec; 24(1):80. PubMed ID: 38124194
[TBL] [Abstract][Full Text] [Related]
35. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
McFarlane T; Zajac JD; Cheung AS
Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
[TBL] [Abstract][Full Text] [Related]
36. Sublingual Estradiol Is Associated with Higher Estrone Concentrations than Transdermal or Injectable Preparations in Transgender Women and Gender Nonbinary Adults.
Cirrincione LR; Winston McPherson G; Rongitsch J; Sadilkova K; Drees JC; Krasowski MD; Dickerson JA; Greene DN
LGBT Health; 2021; 8(2):125-132. PubMed ID: 33439749
[No Abstract] [Full Text] [Related]
37. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
[TBL] [Abstract][Full Text] [Related]
38. Incidence and Risk Factors for Postoperative Venous Thromboembolism After Gender Affirming Vaginoplasty: A Retrospective Analysis of a Large Insurance Claims Database.
Snyder L; Hebert KJ; Horns JJ; Schardein J; McCormick BJ; Downing J; Dy GW; Goodwin I; Agarwal C; Hotaling JM; Myers JB
Urology; 2023 Dec; 182():95-100. PubMed ID: 37774849
[TBL] [Abstract][Full Text] [Related]
39. Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature.
Tang GT; Zwickl S; Sinclair R; Zajac JD; Cheung AS
Clin Exp Dermatol; 2023 Sep; 48(10):1117-1127. PubMed ID: 37311161
[TBL] [Abstract][Full Text] [Related]
40. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
